Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design: Miniperspective
The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
As a central regulator of metabolism, the AMP-activated protein kinase (AMPK) is an established therapeutic target for metabolic diseases. Beyond the metabolic area, the number of medical fields that involve AMPK grows continuously, expanding the potential applications for AMPK modulators. Even though indirect AMPK activators are used in the clinics for their beneficial metabolic outcome, the few described direct agonists all failed to reach the market to date, which leaves options open for novel targeting methods. As AMPK is not actually a single molecule and has different roles depending on its isoform composition, the opportunity for isoform-specific targeting has notably come forward, but the currently available modulators fall short of expectations. In this review, we argue that with the amount of available structural and ligand data, computer-based drug design offers a number of opportunities to undertake novel and isoform-specific targeting of AMPK.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“irreversible AMPK blockade in hypoxic-ischemic brain damage was shown to exacerbate neuronal death [59].”
From AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma (2021) · cites this paper as [59]
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces
Wells, J. A., & McClendon, C. L. (2007) · Nature · doi:10.1038/nature06526 · Cited by 1,960
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943
Cool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 925
Cantó, C., Jiang, L. Q., Deshmukh, A. S., Mataki, C., Coste, A., Lagouge, M., Zierath, J. R., & Auwerx, J. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.006 · Cited by 921
The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase
Hawley, S. A., Fullerton, M. D., Ross, F. A., Schertzer, J. D., Chevtzoff, C., Walker, K. J., Peggie, M. W., Zibrova, D., Green, K. A., Mustard, K. J., et al. (2012) · Science · doi:10.1126/science.1215327 · Cited by 739
Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637
Estimation of the size of drug-like chemical space based on GDB-17 data
Polishchuk, P. G., Madzhidov, T. I., & Varnek, A. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9672-4 · Cited by 619
Structural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Hardie, D. G. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.013 · Cited by 583
Jørgensen, S. B., Viollet, B., Andreelli, F., Frøsig, C., Birk, J. B., Schjerling, P., Vaulont, S., Richter, E. A., & Wojtaszewski, J. F. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306205200 · Cited by 553
Structural basis of AMPK regulation by small molecule activators
Xiao, B., Sanders, M. J., Carmena, D., Bright, N. J., Haire, L. F., Underwood, E., Patel, B. R., Heath, R. B., Walker, P. A., Hallen, S., et al. (2013) · Nature Communications · doi:10.1038/ncomms4017 · Cited by 543
Sullivan, J. E., Brocklehurst, K. J., Marley, A. E., Carey, F., Carling, D., & Beri, R. K. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01006-4 · Cited by 485
AMPK at the Nexus of Energetics and Aging
Burkewitz, K., Zhang, Y., & Mair, W. B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.002 · Cited by 483
Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase
Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R., & Abraham, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143685 · Cited by 441
SALT, I., CELLER, J. W., HAWLEY, S. A., PRESCOTT, A., WOODS, A., CARLING, D., & HARDIE, D. G. (1998) · Biochemical Journal · doi:10.1042/bj3340177 · Cited by 437
Wojtaszewski, J. F. P., Nielsen, P., Hansen, B. F., Richter, E. A., & Kiens, B. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-1-00221.x · Cited by 435
The Glycogen-Binding Domain on the AMPK β Subunit Allows the Kinase to Act as a Glycogen Sensor
McBride, A., Ghilagaber, S., Nikolaev, A., & Hardie, D. G. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.008 · Cited by 432
AMPK activation: a therapeutic target for type 2 diabetes?
Saha, A., Coughlan, K., Valentine, R., & Ruderman, N. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s43731 · Cited by 429
AMPK β Subunit Targets Metabolic Stress Sensing to Glycogen
Polekhina, G., Gupta, A., Michell, B. J., van Denderen, B., Murthy, S., Feil, S. C., Jennings, I. G., Campbell, D. J., Witters, L. A., Parker, M. W., et al. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00292-6 · Cited by 423
O'Neill, H. M., Maarbjerg, S. J., Crane, J. D., Jeppesen, J., Jørgensen, S. B., Schertzer, J. D., Shyroka, O., Kiens, B., van Denderen, B. J., Tarnopolsky, M. A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105062108 · Cited by 406
AMPK inhibition in health and disease
Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., & Andreelli, F. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.488215 · Cited by 383
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
Fogarty, S., & Hardie, D. G. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.012 · Cited by 350
Hudson, E. R., Pan, D. A., James, J., Lucocq, J. M., Hawley, S. A., Green, K. A., Baba, O., Terashima, T., & Hardie, D. G. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00249-5 · Cited by 332
AMPK: Lessons from transgenic and knockout animals
Viollet, B. (2009) · Frontiers in bioscience · doi:10.2741/3229 · Cited by 314
Predicting druggable binding sites at the protein–protein interface
Fuller, J. C., Burgoyne, N. J., & Jackson, R. M. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.10.009 · Cited by 310
AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels
Hardie, D. G. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161148 · Cited by 281
Zhang, Y.-L., Guo, H., Zhang, C.-S., Lin, S.-Y., Yin, Z., Peng, Y., Luo, H., Shi, Y., Lian, G., Zhang, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.005 · Cited by 270
Scott, J. W., van Denderen, B. J. W., Jorgensen, S. B., Honeyman, J. E., Steinberg, G. R., Oakhill, J. S., Iseli, T. J., Koay, A., Gooley, P. R., Stapleton, D., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.005 · Cited by 252
AMP-activated protein kinase, stress responses and cardiovascular diseases
Wang, S., Song, P., & Zou, M.-H. (2012) · Clinical Science · doi:10.1042/cs20110625 · Cited by 245
Kerkela, R., Woulfe, K. C., Durand, J., Vagnozzi, R., Kramer, D., Chu, T. F., Beahm, C., Chen, M. H., & Force, T. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2008.00090.x · Cited by 242
Structural basis of AMPK regulation by adenine nucleotides and glycogen
Li, X., Wang, L., Zhou, X. E., Ke, J., de Waal, P. W., Gu, X., Tan, M. H. E., Wang, D., Wu, D., Xu, H. E., et al. (2015) · Cell Research · doi:10.1038/cr.2014.150 · Cited by 188
Structural Basis for Glycogen Recognition by AMP-Activated Protein Kinase
Polekhina, G., Gupta, A., van Denderen, B. J. W., Feil, S. C., Kemp, B. E., Stapleton, D., & Parker, M. W. (2005) · Structure · doi:10.1016/j.str.2005.07.008 · Cited by 186
Calabrese, M. F., Rajamohan, F., Harris, M. S., Caspers, N. L., Magyar, R., Withka, J. M., Wang, H., Borzilleri, K. A., Sahasrabudhe, P. V., Hoth, L. R., et al. (2014) · Structure · doi:10.1016/j.str.2014.06.009 · Cited by 179
Small Molecule Antagonizes Autoinhibition and Activates AMP-activated Protein Kinase in Cells
Pang, T., Zhang, Z.-S., Gu, M., Qiu, B.-Y., Yu, L.-F., Cao, P.-R., Shao, W., Su, M.-B., Li, J.-Y., Nan, F.-J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710114200 · Cited by 154
What has virtual screening ever done for drug discovery?
Clark, D. E. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.8.841 · Cited by 148
5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells.
Sabina, R. L., Patterson, D., & Holmes, E. W. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)88943-8 · Cited by 146
Fogarty, S., Hawley, S. A., Green, K. A., Saner, N., Mustard, K. J., & Hardie, D. G. (2010) · Biochemical Journal · doi:10.1042/bj20091372 · Cited by 140
Hasinoff, B. B., Patel, D., & O’Hara, K. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.050104 · Cited by 135
Iseli, T. J., Walter, M., van Denderen, B. J. W., Katsis, F., Witters, L. A., Kemp, B. E., Michell, B. J., & Stapleton, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412993200 · Cited by 134
How far can virtual screening take us in drug discovery?
Kar, S., & Roy, K. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.761204 · Cited by 127
High-throughput andin silicoscreenings in drug discovery
Phatak, S. S., STEPHAN, C. C., & Cavasotto, C. N. (2009) · Expert Opinion on Drug Discovery · doi:10.1517/17460440903190961 · Cited by 124
Mechanism of Action of Compound-13: An α1-Selective Small Molecule Activator of AMPK
Hunter, R. W., Foretz, M., Bultot, L., Fullerton, M. D., Deak, M., Ross, F. A., Hawley, S. A., Shpiro, N., Viollet, B., Barron, D., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.05.014 · Cited by 123
AMPK in cardiovascular health and disease
Shirwany, N. A., & Zou, M.-H. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.139 · Cited by 122
The double-edged sword of AMPK signaling in cancer and its therapeutic implications
Jeon, S.-M., & Hay, N. (2015) · Archives of Pharmacal Research · doi:10.1007/s12272-015-0549-z · Cited by 112
Treebak, J. T., Birk, J. B., Hansen, B. F., Olsen, G. S., & Wojtaszewski, J. F. P. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00051.2009 · Cited by 109
Conserved regulatory elements in AMPK
Chen, L., Xin, F., Wang, J., Hu, J., Zhang, Y., Wan, S., Cao, L., Lu, C., Li, P., Yan, S. F., et al. (2013) · Nature · doi:10.1038/nature12189 · Cited by 108
Self-citationThe signaling hubs at the crossroad of longevity and age-related disease networks
Wolfson, M., Budovsky, A., Tăcutu, R., & Fraifeld, V. E. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.026 · Cited by 104
AMPK: An emerging target for modification of injury-induced pain plasticity
Price, T. J., & Dussor, G. O. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.060 · Cited by 103
Sable, R. V., & Jois, S. D. S. (2015) · Molecules · doi:10.3390/molecules200611569 · Cited by 99
Structural Insight into AMPK Regulation: ADP Comes into Play
Jin, X., Townley, R. A., & Shapiro, L. S. (2007) · Structure · doi:10.1016/j.str.2007.07.017 · Cited by 94
A Potent and Selective AMPK Activator That Inhibits de Novo Lipogenesis
Gómez-Galeno, J. E., Dang, Q., Nguyen, T. H., Boyer, S. H., Grote, M. P., Sun, Z., Chen, M., Craigo, W. A., van Poelje, P. D., MacKenna, D. A., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100143q · Cited by 91
Carling, D., & Viollet, B. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.005 · Cited by 89
Targeting AMPK for cardiac protection: Opportunities and challenges
Kim, M., & Tian, R. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.12.004 · Cited by 87
The super super-healing MRL mouse strain
Heydemann, A. (2012) · Frontiers in Biology · doi:10.1007/s11515-012-1192-4 · Cited by 84
Function of the master energy regulator adenosine monophosphate‐activated protein kinase in stroke
Manwani, B., & McCullough, L. D. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23207 · Cited by 81
Fox, M. M., Phoenix, K. N., Kopsiaftis, S., & Claffey, K. P. (2013) · Genes & Cancer · doi:10.1177/1947601913486346 · Cited by 80
Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 77
Aburai, N., Yoshida, M., Ohnishi, M., & Kimura, K. (2010) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.90735 · Cited by 77
Garcia-Haro, L., Garcia-Gimeno, M. A., Neumann, D., Beullens, M., Bollen, M., & Sanz, P. (2010) · The FASEB Journal · doi:10.1096/fj.10-166306 · Cited by 73
Self-citationAMPK isoform expression in the normal and failing hearts
Kim, M., Shen, M., Ngoy, S., Karamanlidis, G., Liao, R., & Tian, R. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.01.016 · Cited by 71
Chen, Z., Shen, X., Shen, F.-Y., Zhong, W., Wu, H., Liu, S., & Jiang, L. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1568-z · Cited by 69
Novel small-molecule AMPK activator orally exerts beneficial effects on diabetic db/db mice
Li, Y., Yu, L.-F., Zhang, L., Qiu, B., Su, M., Wu, F., Chen, D.-K., Pang, T., Gu, M., Zhang, W., et al. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.09.006 · Cited by 68
Yu, L.-F., Li, Y., Su, M., Zhang, M., Zhang, W., Zhang, L.-N., Pang, T., Zhang, R., Liu, B., Li, J.-Y., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400028q · Cited by 66
Scott, J. W., Galić, S., Graham, K. L., Foitzik, R. C., Ling, N. X. Y., Dite, T. A., Issa, S. M. A., Langendorf, C. G., Weng, Q. P., Thomas, H. E., et al. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.05.011 · Cited by 65
AMPK β subunits display isoform specific affinities for carbohydrates
Koay, A., Woodcroft, B., Petrie, E. J., Yue, H., Emanuelle, S., Bieri, M., Bailey, M. F., Hargreaves, M., Park, J.-T., Park, K.-H., et al. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.015 · Cited by 65
Self-citationWu, J., Puppala, D., Feng, X., Monetti, M., Lapworth, A. L., & Geoghegan, K. F. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508747 · Cited by 64
Direct AMP-activated protein kinase activators: a review of evidence from the patent literature
Giordanetto, F., & Karis, D. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.743994 · Cited by 63
Feeding Uninvited Guests: mTOR and AMPK Set the Table for Intracellular Pathogens
Brunton, J., Steele, S. P., Ziehr, B., Moorman, N. J., & Kawula, T. H. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003552 · Cited by 61
Rana, S., Blowers, E. C., & Natarajan, A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm401994c · Cited by 61
Laderoute, K. R., Calaoagan, J. M., Madrid, P. B., Klon, A. E., & Ehrlich, P. J. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.1.12162 · Cited by 54
Jensen, T. E., Ross, F. A., Kleinert, M., Sylow, L., Knudsen, J. R., Gowans, G. J., Hardie, D. G., & Richter, E. A. (2015) · Biochemical Journal · doi:10.1042/bj20141142 · Cited by 52
Choi, K. C., Mollapour, E., Choi, J. H., & Shears, S. B. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.044628 · Cited by 52
Moon, S., Han, D., Kim, Y., Jin, J., Ho, W., & Kim, Y. (2014) · Scientific Reports · doi:10.1038/srep04376 · Cited by 46
Wang, L., & Brautigan, D. L. (2013) · Nature Communications · doi:10.1038/ncomms2565 · Cited by 38
Scholz, R., Suter, M., Weimann, T., Polge, C., Konarev, P. V., Thali, R. F., Tuerk, R. D., Viollet, B., Wallimann, T., Schlattner, U., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047670 · Cited by 36
Self-citationLocalisation of AMPK γ subunits in cardiac and skeletal muscles
Pinter, K., Grignani, R. T., Watkins, H., & Redwood, C. (2013) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-013-9359-4 · Cited by 36
Mobbs, J. I., Koay, A. Z., Paolo, A. D., Bieri, M., Petrie, E. J., Gorman, M. A., Doughty, L., Parker, M. W., Stapleton, D., Griffin, M. D. W., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150270 · Cited by 32
AMP-activated protein kinase modulators: a patent review (2006 – 2010)
Yun, H., & Ha, J. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.577069 · Cited by 31
Sanguinarine is an allosteric activator of AMP-activated protein kinase
Choi, J., He, N., Sung, M., Yang, Y. D., & Yoon, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.081 · Cited by 27
Past strategies and future directions for identifying AMP-activated protein kinase (AMPK) modulators
Sinnett, S. E., & Brenman, J. E. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.008 · Cited by 26
Spérandio, O., Miteva, M. A., Segers, K., Nicolaes, G. A. F., & Villoutreix, B. O. (2008) · The Open Biochemistry Journal · doi:10.2174/1874091x00802010029 · Cited by 23
Self-citationMachrouhi, F., Ouhamou, N., Laderoute, K. R., Calaoagan, J. M., Bukhtiyarova, M., Ehrlich, P. J., & Klon, A. E. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.088 · Cited by 21
Come to Where Insulin Resistance Is, Come to AMPK Country
Nogueiras, R., Diéguez, C., & López, M. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.021 · Cited by 13
Berhanu, T. K., Holley-Cuthrell, J., Roberts, N. W., Mull, A. J., & Heydemann, A. (2014) · Physiological Reports · doi:10.1002/phy2.252 · Cited by 10
Chapnik, N., Genzer, Y., Ben‐Shimon, A., Niv, M. Y., & Froy, O. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0625 · Cited by 9
Cited by
Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds
Marín-Aguilar, F., Pavillard, L., Giampieri, F., Bullón, P., & Cordero, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020288 · Cited by 98
Promise and challenges for direct small molecule AMPK activators
Olivier, S., Foretz, M., & Viollet, B. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.049 · Cited by 85
Belforte, N., Agostinone, J., Alarcon-Martinez, L., Villafranca-Baughman, D., Dotigny, F., Cueva Vargas, J. L., & Di Polo, A. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00466-z · Cited by 67
“For example, irreversible AMPK blockade in hypoxic-ischemic brain damage was shown to exacerbate neuronal death [59].”
BackgroundCameron, K. O., & Kurumbail, R. G. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.09.065 · Cited by 45
Targeting AMPK: From Ancient Drugs to New Small-Molecule Activators
Guigas, B., & Viollet, B. (2016) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-319-43589-3_13 · Cited by 46
Metadata
- Authors
- Miglianico, M., Nicolaes, G. A. F., & Neumann, D.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Miglianico, Marie
- Neumann, Dietbert
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2015-11-09
- Volume
- 59
- Issue
- 7
- Pages
- 2879-2893
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2340359231
- Cited by
- 24
- References
- 89
- Citations by year
- 2023: 1 · 2022: 1 · 2021: 4 · 2020: 3 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 4
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (864.10.007, 91112016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- AMPK, AMPK agonists, AMPK isoforms, computer-aided drug design, metabolic disorders, kinase inhibitors, structure-based drug design
- MeSH terms
- Animals, Brain, Enzyme Activation, Humans, Insulin Resistance, Ligands, Neoplasms, Structure-Activity Relationship, Drug Design, Signal Transduction, Computer-Aided Design, Protein Kinase Inhibitors, AMP-Activated Protein Kinases, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.